These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 33984100)

  • 61. Neurologic manifestations of COVID-19 infection in Asia: a systematic review.
    Widyadharma IPE; Hendellyn A; Laksmi Dewi AAAP; Adnyana IMO; Samatra DPGP; Utami DKI
    Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):28. PubMed ID: 33613024
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Guillain-Barré syndrome and SARS-CoV-2.
    Lampe A; Winschel A; Lang C; Steiner T
    Neurol Res Pract; 2020; 2(1):19. PubMed ID: 32835165
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Direct and Indirect Neurological Signs of COVID-19.
    Gromova OA; Torshin IY; Semenov VA; Putilina MV; Chuchalin AG
    Neurosci Behav Physiol; 2021; 51(7):856-866. PubMed ID: 34751196
    [No Abstract]   [Full Text] [Related]  

  • 64. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
    Abu-Rumeileh S; Abdelhak A; Foschi M; Tumani H; Otto M
    J Neurol; 2021 Apr; 268(4):1133-1170. PubMed ID: 32840686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.
    Keyhanian K; Umeton RP; Mohit B; Davoudi V; Hajighasemi F; Ghasemi M
    J Neuroimmunol; 2020 Nov; 350():577436. PubMed ID: 33212316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Possible association between Guillain-Barré syndrome and SARS-CoV-2 infection in children: A case report and literature review.
    Mussinatto I; Benevenuta C; Caci A; Calvo MM; Impastato M; Barra M; Genovese E; Timeus F
    Exp Ther Med; 2022 Jul; 24(1):462. PubMed ID: 35747147
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neurological complications of SARS-CoV-2: A single-center case series authors.
    Hassan M; Khan NU; Iqbal M; Jan Z; Rajput HM; Dewey RS; Badshah M
    Brain Hemorrhages; 2021 Dec; 2(4):161-164. PubMed ID: 34545348
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms.
    Sarıoğlu E; Sarıaltın SY; Çoban T
    Brain Hemorrhages; 2023 Sep; 4(3):154-173. PubMed ID: 36789140
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radiological Manifestation of Neurological Complications in the Course of SARS-CoV-2 Infection.
    Sklinda K; Dorobek M; Wasilewski PG; Dreżewski K; Dȩbicka M; Walecki J; Mruk B
    Front Neurol; 2021; 12():711026. PubMed ID: 34744963
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic.
    Özdağ Acarli AN; Samanci B; Ekizoğlu E; Çakar A; Şirin NG; Gündüz T; Parman Y; Baykan B
    Noro Psikiyatr Ars; 2020 Jun; 57(2):154-159. PubMed ID: 32550783
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neurological Complications of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis.
    Panda PK; Sharawat IK; Panda P; Natarajan V; Bhakat R; Dawman L
    J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32910826
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanistic Episodes on SARS-CoV-2-Mediated Neurological Manifestations and Their Possible Therapeutic Interventions.
    Nida S; Srinivisan H; Pandurangan AK; Waseem M
    J Environ Pathol Toxicol Oncol; 2022; 41(1):85-98. PubMed ID: 35378006
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders.
    Singh AK; Bhushan B; Maurya A; Mishra G; Singh SK; Awasthi R
    Dermatol Ther; 2020 Jul; 33(4):e13591. PubMed ID: 32412679
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.
    D V; Sharma A; Kumar A; Flora SJS
    ACS Chem Neurosci; 2021 Aug; 12(15):2776-2797. PubMed ID: 34260855
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Noteworthy Neurological Manifestations Associated With COVID-19 Infection.
    Elkhouly A; Kaplan AC
    Cureus; 2020 Jul; 12(7):e8992. PubMed ID: 32775074
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential.
    Haddadi K; Asadian L
    Iran J Med Sci; 2020 Sep; 45(5):325-332. PubMed ID: 33060875
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Concomitant Guillain-Barre syndrome with COVID-19: a case report.
    Mackenzie N; Lopez-Coronel E; Dau A; Maloof D; Mattar S; Garcia JT; Fontecha B; Lanata CM; Guillen-Burgos HF
    BMC Neurol; 2021 Mar; 21(1):135. PubMed ID: 33757457
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Case Report: Postacute Rehabilitation of Guillain-Barré Syndrome and Cerebral Vasculitis-Like Pattern Accompanied by SARS-CoV-2 Infection.
    Colonna S; Sciumé L; Giarda F; Innocenti A; Beretta G; Dalla Costa D
    Front Neurol; 2020; 11():602554. PubMed ID: 33488499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.